Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach
- 20 July 2023
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 196 (4) , 2110-2121
Abstract
Epidermal growth factor receptor (EGFR) is the most frequently overexpressed receptor histologically exhibited by oral squamous cell carcinoma (OSCC) patients. Aberrated EGFR signaling may lead to recurrence and metastasis, thus laying the foundation of targeted therapy. Deactivating EGFR is likely to prevent downstream signaling thus resulting in apoptosis. Tyrosine kinase inhibitors (TKIs) have come into play to revert aggressiveness of OSCC. We exploited comparative proteomic analyses based on anti‐EGFR potential of varlitinib, using cellular proteomes from treated and untreated groups of oral cancer cells to identify protein players functional during oral carcinogenesis. Following separation by two-dimensional electrophoresis, differentially expressed cellular proteins (varlitinib-treated and untreated cells) were analyzed and later identified using QTOF mass spectrometer. In silico analysis for protein–protein interaction was carried out using STRING. Six differentially expressed proteins were identified as binding immunoglobulin protein (BiP), heat shock protein 7 C (HSP7C), protein disulfide isomerase 1 A (PDIA1), vimentin (VIME), keratin type I cytoskeletal 14 (K1C14), and β-Actin (ACTB). Relative expression of five proteins was found to be downregulated upon varlitinib treatment, whereas only K1C14 was upregulated in treated cells compared to control. Protein network analysis depicts the interaction between BiP, PDIA1, VIME, etc. indicating their role in oral carcinogenesis. Oral cancer cells show proteome shift based on varlitinib treatment compared to corresponding controls. Our data suggest candidature of varlitinib as a potent therapeutic agent and BiP, PDIA1, HSP7C, VIME, and β-Actin as complementary/prognostic markers of OSCC.Keywords
Funding Information
- University of Karachi (NCP 2019)
This publication has 36 references indexed in Scilit:
- Detection of autoantibodies against heat shock proteins and collapsin response mediator proteins in autoimmune retinopathyBMC Ophthalmology, 2013
- The HSP70 family and cancerCarcinogenesis, 2013
- Systemic therapy in the management of metastatic or advanced salivary gland cancersHead & Neck Oncology, 2012
- The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapiesOncogene, 2012
- Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cellsMolecular Biology of the Cell, 2011
- Vimentin in cancer and its potential as a molecular target for cancer therapyCellular and Molecular Life Sciences, 2011
- Measuring ER Stress and the Unfolded Protein Response Using Mammalian Tissue Culture System2011
- Proteomic analysis of the tumorigenic human prostate cell line M12 after microcell‐mediated transfer of chromosome 19 demonstrates reduction of vimentinElectrophoresis, 2003
- Molecular Biology of Human Oral CancerCritical Reviews in Oral Biology & Medicine, 1996
- Epidermal growth factor-related peptides and their receptors in human malignanciesCritical Reviews in Oncology/Hematology, 1995